June 21, 2019
Health Level Seven International® invites you to take part in the early ballot openings for balloting HL7 candidate standards and documents for the upcoming September 2019 ballot cycle.
The candidate standards and other documents described in this announcement are balloting prior to HL7's September 2019 Working Group Meeting (WGM). Comments received from consensus group members will be addressed at that WGM running September 14-20, 2019 in Atlanta GA USA.
Ballot Period Open/Close Dates
Voting for consensus group members in most ballots in this document will open and close on the following dates. Exceptions for a specific ballot are listed with that ballot description.
Ballot Open Date: Friday, June 21, 2019
Ballot Close Date: Monday, July 22, 2019
Consensus Group Enrollment Period
Consensus Group Enrollment Period is now closed
Important Note: Consensus group signup closes when ballot voting begins.
Changes from the initial announcement are identified in the Update to Ballot Announcement for September 2019 Ballot Cycle document released when this ballot cycle opens.
All those engaged in balloting should be informed that any subsequent ballot of material previously balloted at the normative level will supersede all previous ballots. Any votes or comments from previous ballots will not count towards the new normative ballot; for any comments to be considered again, voters will need to cast a new ballot with comments.
The grid below provides the name of the sponsoring and co-sponsoring Work Group(s) announcing the ballot opening for the ballot listed. Those interested in ballots for a certain attribute can sort the grid: by Work Group, or by product family for example,
|Work Group||Project ID||Ballot Name||Family||Ballot Iteration||Ballot Description||Last Balloted||Unique Ballot ID|
|Clinical Interoperability Council||1494||* HL7 FHIR® Implementation Guide: Health Record Exchange (HRex) Framework, Release 1- US Realm||FHIR||1st STU Ballot||The scope of the HRex Framework project is to define combinations of exchange methods, specific payloads, search criteria, conformance, provenance, and other relevant requirements to support specific exchanges of clinical information between: 1) providers, 2) a provider and a payer, 3) a payer and providers, and/or a provider and any third party involved in value based care.
||Since the last ballot of this material in 2019SEP , the following changes have been made: N/A||FHIR_IG_HRex_R1_D1_2019SEP|
|Patient Care||1495||* HL7 FHIR® Implementation Guide: Clinical Data Exchange (CDex), Release 1- US Realm||FHIR||1st STU Ballot||The scope of the CDex project is to defined combinations of exchange methods (push, pull, subscribe, CDS Hooks, …), specific payloads (Documents, Bundles, and Individual Resources), search criteria, conformance, provenance, and other relevant requirements to support specific exchanges of clinical information between provider and other providers and/or payers.||Since the last ballot of this material in 2019SEP , the following changes have been made: N/A||FHIR_IG_CDex_R1_D1_2019SEP|
|Patient Care||1489||* HL7 FHIR® Implementation Guide: Payer Data Exchange (PDex), Release 1 - US Realm||FHIR||1st STU Ballot||This Implementation Guide will describe exchange methods (push, pull, triggers, subscription), use of other interoperability 'standards' (e.g. CDS Hooks and SMART on FHIR) and specific use of FHIR resources to effectively exchange payer information regarding the current or previous care, including the provenance of the data, of one or more specific patients/members with a provider responsible for evaluating/specifying/ordering/delivering care for the patient.||Since the last ballot of this material in 2019SEP , the following changes have been made: None.||FHIR_IG_PDex_R1_D1_2019SEP|
|Pharmacy||1489||* HL7 FHIR® Implementation Guide: Payer Data Exchange (PDex) Drug Formulary, Release 1 - US Realm||FHIR||1st STU Ballot||This guide will define the exchange methods and interoperability "standards" and specific use of FHIR resources to support Health Plan member-authorized exchange of Health Plan drug formulary information for members and third-party applications.||Since the last ballot of this material in 2019SEP , the following changes have been made: N/A||FHIR_IG_PDex_FORMULARY_R1_D1_2019SEP|
|Structured Documents||1526||* HL7 CDA® R2 IG: CCDA Templates for Clinical Notes STU Companion Guide, Release 2- US Realm||CDA||1st STU Ballot||The Office of the National Coordinator (ONC) releases periodic proposed rules, and final rules, which reference the use of Consolidated CDA (C-CDA). The Companion Guide to Consolidated Clinical Document Architecture (C-CDA) provides supplemental guidance to the Health Level Seven (HL7) CDA® R2 IG: C-CDA Templates for Clinical Notes STU. The prior version of the companion guide is specific to a rule, the 2015 ONC Certification rule.||Since the last ballot of this material in 2019SEP , the following changes have been made: The guide has been updated to make it rule independent now and will consider any necessary updates to supplement the C-CDA Standard to meet current and proposed regulations. New C-CDA templates to support USCDI will be considered. Future regulations when published may also be considered appropriate for the scope of this project.||CDAR2_IG_CCDA_COMPANION_R2_D1_2019SEP|
For more information on ballot procedure, such as general guidelines, and voting, see Ballot Procedures and Guidelines